Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The investigators leading hypotheses are:
- Oral therapy with montelukast may lead to improved sleep study findings in children with
mild to moderate Obstructive Sleep Apnea Syndrome (OSAS) who require surgical removal of
adenoids and tonsils for OSAS.
- A significant proportion of the children with OSAS treated with montelukast will show
reduced severity of OSAS, and this will remove the need for surgical intervention.